Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

PURPOSE: Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall survival. Insulin resistance is defined as a pathological condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Alan, Ozkan, Akin Telli, Tugba, Aktas, Bilge, Koca, Sinan, Ökten, Ilker Nihat, Hasanov, Rahib, Basoglu, Tugba, Arikan, Rukiye, Demircan, Nazim Can, Ercelep, Ozlem, Kaya, Serap, Ugurlu, Mustafa Umit, Kaya, Handan, Akgul Babacan, Nalan, Dane, Faysal, Yumuk, Perran Fulden
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488234/
https://www.ncbi.nlm.nih.gov/pubmed/32907593
http://dx.doi.org/10.1186/s12957-020-02019-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488234/
https://www.ncbi.nlm.nih.gov/pubmed/32907593
http://dx.doi.org/10.1186/s12957-020-02019-y

Ejemplares similares